What it is
BPC-157 is a synthetic 15-amino-acid peptide studied mostly in laboratory and animal models. It is promoted online for tendon, muscle, gastrointestinal, and injury recovery claims.
What the evidence can tell us
Preclinical studies generate hypotheses about tissue and signalling effects. Published human evidence is sparse, and registered trials do not by themselves establish benefit. There is not enough controlled human evidence to support the breadth or certainty of common online claims.
Canadian context
Health Canada’s April 2026 advisory names BPC-157 as an unauthorized injectable peptide drug consumers should not buy or use. No authorized BPC-157 drug product was identified in the Drug Product Database on the date checked.
Key unknowns
Human efficacy, dose-response, long-term safety, interactions, immunologic effects, and risks across formulations remain uncertain. Unauthorized injectables add risks involving sterility, contamination, potency, and identity.
Read the complete BPC-157 evidence and status guide.
Source trail